azaCITIDine
Pronunciation: ay-za-SYE-ti-deen
Other Name(s): Vidaza®
Appearance: White, milky liquid
Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.
Drug Monograph
Sep 2025
Eligibility Forms
Azacitidine - Acute Myeloid Leukemia (AML) Azacitidine - Acute Myeloid Leukemia (AML) Greater Than 30 Percent Blasts Azacitidine in combination with Venetoclax (Outpatient) - Previously Untreated Acute Myeloid Leukemia Azacitidine in combination with Venetoclax (Inpatient) - Previously Untreated Acute Myeloid Leukemia Azacitidine - Intermediate-2 and High-Risk Myelodysplastic Syndrome (MDS) Azacitidine in combination with Ivosidenib (Outpatient) - Previously Untreated Acute Myeloid Leukemia Azacitidine in combination with Ivosidenib (Inpatient) - Previously Untreated Acute Myeloid LeukemiaPatient Info Sheet
Aug 2023
What it is used for
- For treating certain types of blood cancers, such as myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)